General contact

Head Office
Novartis International AG
CH-4002 Basel
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 - 17:00, GMT+1
(Central European Time)

Investors

Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel
Switzerland

+41 61 324 79 44

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

Corporate responsibility

Novartis seeks to ease suffering and enhance the quality of life of patients. Access-to-medicine programs at Novartis target diseases from malaria and leprosy to tuberculosis and cancer. Moreover, Novartis finances research institutes with nonprofit missions – to discover new medicines and vaccines specifically tailored to the needs of developing countries.

Malaria patient and mother in Tanzania
Malaria patient and mother in Tanzania
Malaria patient and mother in Tanzania
Malaria patient and mother in Tanzania
Malaria patient and mother in Tanzania
Malaria patient and mother in Tanzania
Malaria patient and mother in Tanzania
Malaria patient and mother in Tanzania
Malaria patient and mother in Tanzania
Patient in health facility Tanzania
Patient in health facility Tanzania
Patient in health facility Tanzania
Novartis Comprehensive Leprosy Care Program, India
Novartis Comprehensive Leprosy Care Program, India
Novartis Comprehensive Leprosy Care Program, India
You may use the multimedia material provided in this section for commercial purposes only in relation to Novartis. These images must not be modified in any way and each item must have the copyright acknowledgement of Novartis AG (© Novartis AG).